<DOC>
	<DOCNO>NCT02423993</DOCNO>
	<brief_summary>The purpose study assess effectiveness structure group education glycemic control Quality Life ( QoL ) among user continuous subcutaneous insulin infusion ( CSII ) .</brief_summary>
	<brief_title>Education Effectiveness Type 1 Diabetes Mellitus Insulin Pump Therapy</brief_title>
	<detailed_description>The study include 80 patient type 1 diabetes transfer multiple daily injection ( MDI ) regimen continuous subcutaneous insulin infusion ( CSII ) . All patient divide 2 group : 1 ) structure education group ( n=40 ) 2 ) control group ( n=40 ) . Patients structured education group transfer MDI CSII use special structured education program type 1 diabetes patient insulin pump therapy . Before transfer CSII patient group randomize two subgroup , depend type blood glucose control : patient use CSII self-monitoring blood glucose ( SMBG ) ( n=20 ) patient use sensor-augmented pump ( SAP ) ( n=20 ) . Follow-up duration structure education group 4 month ; follow-up visit include treatment adjustment , glucose data review collection data adverse event every 4 week . Between visit , communication clinician initiate discretion patient . The control group include patient type 1 diabetes use CSII 4-6 month . The patient group divide two subgroup , depend type self blood glucose control : patient use CSII ( n=20 ) SMBG patient use SAP ( n=20 ) . In group patient transfer CSII endocrinologist-specialist CSII technical trainer individually monitor coach specialist local endocrinologist within 4 month prior inclusion . All patient group educate intensive diabetes management , include carbohydrate counting , administration correction dose insulin technical aspect CSII self glucose control continuous glucose monitoring real-time ( `` CGM-RT '' ) . All patient provide write informed consent . Diabetes-management software ( CareLink Therapy Management System Diabetes-Clinical , Medtronic ) use glucose data review include frequency hypoglycemia , assessment frequency bolus calculator use . Diaries self-control analyse glucose data review . The level knowledge basic diabetes self-management assessed use standard questionnaire patient type 1 diabetes . For Quality Life ( QoL ) assessment use follow validated questionnaire ( Russian ) : 1 . The Medical Outcomes Study 36-Item Short Form Health Survey ( SF-36 ) . 2 . The Audit Diabetes-Dependent Quality Life ( ADDQoL ) ( С. Bradley et al. , 1999 , adjust Starostina E.G. , 2003 ) . Patients structured education group complete QoL Questionnaires prior education 4 month transfer CSII . Patients control group complete Questionnaires enrollment . Assessment diabetes complication hold 4 month transfer CSII structured education group time enrollment control group . For knowledge assessment disease management use standard Questionnaire patient type 1 diabetes . Maximum score equal 37 grade ; satisfactory level knowledge score 27 . Patients structural education group complete Questionnaire prior conversion CSII regimen education course 4 month follow . Patients control group complete Questionnaire enrollment . Statistical analysis . Statistica ( StatSoft Inc. , USA , version 8.0 ) software use data processing . The following descriptive statistical parameter use : median , inter-quartile interval ( Me [ 25 ; 75 ] ) mass share ( % ) . Non- parametric criterion use use non-normalized distribution ( Mann - Whitney U-criterion pair comparison independent sample ) . The χ2 criterion use comparison parameter distribution population sample . Non - parametric Spearman 's correlation use correlation analysis . Standard deviation ( M±SD ) use evaluate rate hypoglycemia event , frequency plasma glucose level self-control , utilization bolus calculator , plasma glucose level variability , certain item QoL Questionnaires . A P value le 0.05 consider indicate statistical significance comparison primary outcome , baseline characteristic , safety .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes mellitus ; Disease duration &gt; 1 year ; Patients inform consent , approve participation completion questionnaire . Severe late diabetic complication ( diabetic foot syndrome , painful neuropathy , autonomic neuropathy , significant loss vision , glomerular filtration rate &lt; 30 ml/min/1.73 m2 ) ; Pregnancy ; Severe concomitant disease ; Known psychic disorder and/or treatment psychotropic medicine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Type 1 diabetes mellitus</keyword>
	<keyword>Continuous subcutaneous insulin infusion</keyword>
	<keyword>Quality life</keyword>
	<keyword>Therapeutic education</keyword>
	<keyword>Insulin pump</keyword>
</DOC>